Neuralink, Elon Musk’s brain implant company, has won approval from the U.S. Food and Drug Administration to start testing its device in humans, one of a growing cadre of neurotech pioneers with goals of merging humans with machines to treat a range of medical conditions such as paralysis, blindness and depression—and enhance existing abilities like memory or […]
Yaccarino was a seasoned executive at NBCUniversal who worked on a Covid vaccine campaign and had ties to the World Economic Forum.
A buildup of dust means the rover, which spent months exploring Mars, may never be able to wake up.
The test, capable of detecting Parkinson’s before the onset of symptoms, “launches a new, biological era in Parkinson’s research” and could pave the way for a cure, said researcher Kenneth Marek.
Three plane-sized asteroids—and one the size of a house—are set to pass close by Earth on Wednesday and Thursday, NASA said.
Virgin Orbit, which laid off most of its staff last week, struggled to secure funding after a failed satellite launch from the U.K. in January.
Labs have been “locked in an out-of-control race to develop and deploy ever more powerful digital minds that no one—not even their creators—can understand, predict, or reliably control,” said an open letter signed by the likes of Apple cofounder Steve Wozniak and politician Andrew Yang.
Candida auris, a type of yeast, can trigger lethal, highly invasive infections and is increasingly resistant to what few antifungal drugs we have to treat it.
Oil prices and global shares fell after UBS unveiled plans to buy its struggling Swiss rival Credit Suisse for $3.2 billion over the weekend.
The German sportswear giant has a mountain of unsold Yeezy shoes leftover from its partnership with Ye.